HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the rat.

Abstract
Hemoglobin-based oxygen carriers (HBOC) have been primarily studied for blood loss treatment. More recently infusions of HBOC in euvolemic subjects have been proposed for a wide variety of potential therapies in which increased tissue oxygenation would be beneficial. However, compared with the exchange transfusion models to study blood loss, less is known about HBOC oxygen delivery and vasoacitvity when it is infused in euvolemic subjects. We hypothesized that HBOC [polymerized bovine hemoglobin (PBvHb)] infusion creating hypervolemia would increase oxygen delivery to tissues during acute global hypoxia. Vascular oxygen content and hemodynamics were determined after euvolemic rats were infused with 3 ml of either lactated Ringer or PBvHb solution (13 g/dl, 1.3 g/kg) during acute hypoxia (FIO2 = 10%, 4 h) or normoxia (FIO2 = 21%) exposure. Our data demonstrated that compared with Ringer-infused animals, in hypoxia and normoxia, PBvHb treatment improved oxygen content but raised mean arterial pressure, lowered stroke volume, heart rate, and cardiac index, which resulted in a net reduction in blood flow and oxygen delivery to the tissues. The PBvHb vasoactive effect was similar in magnitude and direction as to the Ringer-infused animals treated with a nitric oxide synthase inhibitor nitro-l-arginine, suggesting the PBvHb effect is mediated via nitric oxide scavenging. We conclude that infusion of PBvHb is not likely to be useful in treating global hypoxia under these conditions.
AuthorsDavid C Irwin, Ben Foreman, Ken Morris, Molly White, Tim Sullivan, Robert Jacobs, Eric Monnet, Tim Hackett, Martha C TissotvanPatot, Karyn L Hamilton, Robert W Gotshall
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 295 Issue 3 Pg. H1090-H1099 (Sep 2008) ISSN: 0363-6135 [Print] United States
PMID18567708 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Blood Substitutes
  • Enzyme Inhibitors
  • Methemoglobin
  • Nitric Oxide Synthase
  • Oxygen
  • NG-Nitroarginine Methyl Ester
Topics
  • Animals
  • Blood Gas Analysis
  • Blood Pressure (drug effects)
  • Blood Substitutes (pharmacology)
  • Cardiac Output (drug effects)
  • Cattle
  • Enzyme Inhibitors (pharmacology)
  • Heart Rate (drug effects)
  • Hypoxia (blood)
  • Male
  • Methemoglobin (analysis)
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Oxygen (blood)
  • Oxygen Consumption (drug effects)
  • Pulmonary Circulation (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Stroke Volume (drug effects)
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: